Current Issue

February 2022

Central Nervous System Malignancies
David A. Reardon, Editor

In this issue of Hematology/Oncology Clinics of North America, we summarize key scientific and treatment updates related to primary and metastatic tumors of the central nervous system (CNS). Tumors of the CNS remain one of the greatest challenges in current medical oncology. Despite nihilistic attitudes that have historically dampened enthusiasm for the treatment of these tumors, the underlying science and clinical care of patients with these tumors continue to markedly evolve. An expanding repertoire of treatment interventions that integrate medical and neuro-oncologists is fueling a growing excitement for achieving better outcomes for these challenging tumors.

Articles in Press

There are no Articles in Press at this time

Most Read


The Clinics Journals

Discover everything the Clinics journals have to offer.

About the Journal

Hematology/Oncology Clinics updates you on the latest trends in patient management, keeps you up to date on the newest advances, and provides a sound basis for choosing treatment options. Under the direction of an experienced guest editor, each issue focuses on a single topic in hematology and oncology, including hemostasis and thrombosis, molecular and cellular basis of hematology, coagulation disorders, and cancers—bone, gastrointestinal, head and neck, lymphomas, neuroendocrine, breast, renal cell, melanoma, and more.
Hematology/Oncology Clinics of North America is published six times each year, in February, April, June, August, October, and December.